Risk factors associated with nocebo effects: A review of reviews
- PMID: 39021437
- PMCID: PMC11252084
- DOI: 10.1016/j.bbih.2024.100800
Risk factors associated with nocebo effects: A review of reviews
Abstract
Objective: This meta-review aims to identify and categorize the risk factors that are associated with nocebo effects. The nocebo effect can exert a negative impact on treatment outcomes and have detrimental outcomes on health. Learning more about its potential predictors and risk factors is a crucial step to mitigating it.
Methods: Literature review studies about the risk factors for nocebo effects were searched through five databases (PubMed, Scopus, The Cochrane Library, PsycINFO, and Embase) and through grey literature. Methodological validity and risk of bias were assessed. We conducted a thematic analysis of the results of the forty-three included reviews.
Results: We identified nine categories of risk factors: prior expectations and learning; socio-demographic characteristics; personality and individual differences; neurodegenerative conditions; inflammatory conditions; communication of information and patient-physician relationship; drug characteristics; setting; and self-awareness. We also highlighted the main biochemical and neurophysiological mechanisms underlying nocebo effects.
Conclusions: Nocebo effects arise from expectations of adverse symptoms, particularly when triggered by previous negative experiences. A trusting relationship with the treating physician and clear, tailored treatment instructions can act as protective factors against a nocebo effect. Clinical implications are discussed.
Keywords: Meta-review; Nocebo; Nocebo mechanisms; Nocebo risk factors.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Negative expectations (nocebo phenomenon) in clinical interventions: A scoping review.J Educ Health Promot. 2024 Mar 28;13:106. doi: 10.4103/jehp.jehp_269_23. eCollection 2024. J Educ Health Promot. 2024. PMID: 38726093 Free PMC article.
-
Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups?Syst Rev. 2014 Feb 21;3:14. doi: 10.1186/2046-4053-3-14. Syst Rev. 2014. PMID: 24555576 Free PMC article.
-
The nocebo effect: a clinicians guide.Aust N Z J Psychiatry. 2013 Jul;47(7):617-23. doi: 10.1177/0004867412464717. Epub 2012 Oct 23. Aust N Z J Psychiatry. 2013. PMID: 23093053 Review.
-
Nocebo and pain: An overview of the psychoneurobiological mechanisms.Pain Rep. 2017 Mar-Apr;2(2):e585. doi: 10.1097/PR9.0000000000000585. Pain Rep. 2017. PMID: 28971165 Free PMC article.
-
Deployment of personnel to military operations: impact on mental health and social functioning.Campbell Syst Rev. 2018 Jun 1;14(1):1-127. doi: 10.4073/csr.2018.6. eCollection 2018. Campbell Syst Rev. 2018. PMID: 37131363 Free PMC article.
Cited by
-
Optimized communication during risk disclosure to reduce nocebo headache after lumbar puncture-a study protocol for a randomized controlled clinical trial.Front Psychol. 2025 Feb 26;16:1521978. doi: 10.3389/fpsyg.2025.1521978. eCollection 2025. Front Psychol. 2025. PMID: 40078436 Free PMC article.
-
Case Report: Practical approach to unmask unspecific adverse effects under lipid-lowering medication.Front Cardiovasc Med. 2025 May 27;12:1604129. doi: 10.3389/fcvm.2025.1604129. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40495982 Free PMC article.
-
Placebo and nocebo phenomena in schizophrenia spectrum disorders: a narrative review on current knowledge and potential future directions.Psychol Med. 2025 Jul 18;55:e199. doi: 10.1017/S0033291725100901. Psychol Med. 2025. PMID: 40676945 Free PMC article. Review.
-
Illness Expectations and Asthma Symptoms: A 6-Month Longitudinal Study.Health Expect. 2025 Jun;28(3):e70285. doi: 10.1111/hex.70285. Health Expect. 2025. PMID: 40325877 Free PMC article.
-
Positive social modeling attenuates nocebo side effects.Ann Behav Med. 2025 Jan 4;59(1):kaaf048. doi: 10.1093/abm/kaaf048. Ann Behav Med. 2025. PMID: 40662257 Free PMC article. Clinical Trial.
References
-
- Barbiani D., Benedetti F. In: Placebo Effect. Suzy Bird G., editor. 2020.
Publication types
LinkOut - more resources
Full Text Sources